Indexed keywords
2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE;
2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE F 18;
FLUORINE 18;
UNCLASSIFIED DRUG;
2-(2-NITRO-1H-IMIDAZOL-1-YL)-N-(2,2,3,3,3-PENTAFLUOROPROPYL)ACETAMIDE;
DRUG DERIVATIVE;
DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;
ETANIDAZOLE;
FLUORINATED HYDROCARBON;
FLUORINE;
RADIOPHARMACEUTICAL AGENT;
ARTICLE;
FLUORINATION;
HYPOXIA;
ISOTOPE LABELING;
METABOLISM;
NONHUMAN;
OXYGEN TENSION;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RAT;
SYNTHESIS;
URINARY EXCRETION;
ANIMAL;
ANOXIA;
CHEMISTRY;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
SCINTISCANNING;
ANIMALS;
ANOXIA;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
ETANIDAZOLE;
FLUORINE RADIOISOTOPES;
HUMANS;
HYDROCARBONS, FLUORINATED;
INDICATORS AND REAGENTS;
RADIOPHARMACEUTICALS;
TOMOGRAPHY, EMISSION-COMPUTED;
ACETIC ACID;
CHEMICAL BONDS;
FLUORINE;
FLUORINE CONTAINING POLYMERS;
HIGH PRESSURE LIQUID CHROMATOGRAPHY;
LIVING SYSTEMS STUDIES;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
OXYGEN;
POSITRON EMISSION TOMOGRAPHY;
SYNTHESIS (CHEMICAL);
TISSUE;
BIODISTRIBUTION;
ELECTROPHILIC FLUORINATION;
FLUORINATED ALKENE BOND;
TISSUE HYPOXIA;
TRIFLUOROACETIC ACID;
RADIOACTIVE TRACERS;
2
0030742027
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
(1997)
International Journal of Radiation Oncology, Biology, Physics
, vol.38
, Issue.2
, pp. 285-289
Brizel, D.M.1
Sibley, G.S.2
Prosnitz, L.R.3
Scher, R.L.4
Dewhrist, M.W.5
6
0028784382
Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]
(1995)
British Journal of Cancer
, vol.72
, Issue.4
, pp. 875-882
Evans, S.M.1
Joiner, B.2
Jenkins, W.T.3
Laughlin, K.M.4
Lord, E.M.5
Koch, C.J.6
8
0033954168
18F]-EF1
Journal of Nuclear Medicine
, vol.41
, Issue.2
, pp. 327-336
Evans, S.M.1
Kachur, A.V.2
Shiue, C.-Y.3
Hustinx, R.4
Jenkins, W.T.5
Shiue, G.G.6
Karp, J.S.7
Alavi, A.8
Lord, E.M.9
Dolbier W.R., Jr.10
Koch, C.J.11
10
0027339592
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix
(1993)
Radiotherapy and Oncology
, vol.26
, Issue.1
, pp. 45-50
Hockel, M.1
Knoop, C.2
Schlenger, K.3
Vorndran, B.4
Baussmann, E.5
Mitze, M.6
Knapstein, P.G.7
Vaupel, P.8
11
0022437135
18F-labeled fluoronitroimidazoles: Potential in vivo markers of hypoxic tissue
(1986)
International Journal of Radiation Applications and Instrumentation, Part A, Applied Radiation and Isotopes
, vol.37
, Issue.7
, pp. 599-605
Jerabek, P.A.1
Patrick, T.B.2
Kilbourn, M.R.3
Dischino, D.D.4
Welch, M.J.5
12
0033486390
18F]-EF1
(1999)
Journal of Applied Radiation and Isotopes
, vol.51
, Issue.6
, pp. 643-650
Kachur, A.V.1
Dolbier W.R., Jr.2
Evans, S.M.3
Shiue, C.-Y.4
Shiue, G.G.5
Skov, K.A.6
Baird, I.R.7
James, B.R.8
Li, A.-R.9
Roche, A.10
Koch, C.J.11
14
0028839715
Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acet amide]: Analysis of drug adducts by fluorescent antibodies vs bound radioactivity
(1995)
British Journal of Cancer
, vol.72
, Issue.4
, pp. 869-874
Koch, C.J.1
Evans, S.M.2
Lord, E.M.3
15
0026570515
Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
(1992)
International Journal of Radiation Oncology, Biology, Physics
, vol.22
, Issue.1
, pp. 199-212
Koh, W.J.1
Rasey, J.S.2
Evans, M.L.3
Grierson, J.R.4
Lewellen, T.K.5
Graham, M.M.6
Krohn, K.A.7
Griffin, T.W.8
17
0030423710
Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl)acet amide) in mice bearing subcutaneous EMT6 tumors
(1996)
Journal of Pharmacology and Experimental Therapeutics
, vol.277
, Issue.2
, pp. 1049-1057
Laughlin, K.M.1
Evans, S.M.2
Jenkins, W.T.3
Tracy, M.4
Chan, C.Y.5
Lord, E.M.6
Koch, C.J.7
19
0023229459
Radiolabeled hypoxic cell sensitizers: Tracers for assessment of ischemia
(1987)
Life Sciences
, vol.41
, Issue.2
, pp. 199-206
Mathias, C.J.1
Welch, M.J.2
Kilbourn, M.R.3
Jerabek, P.A.4
Patrick, T.B.5
Raichle, M.E.6
Krohn, K.A.7
Rasey, J.S.8
Shaw, D.W.9
22
0023638854
Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells
(1987)
Radiation Research
, vol.111
, Issue.2
, pp. 292-304
Rasey, J.S.1
Grunbaum, Z.2
Magee, S.3
Nelson, N.J.4
Olive, P.L.5
Durand, R.E.6
Krohn, K.A.7
23
0030249455
Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients
(1996)
International Journal of Radiation Oncology, Biology, Physics
, vol.36
, Issue.2
, pp. 417-428
Rasey, J.S.1
Koh, W.J.2
Evans, M.L.3
Peterson, L.M.4
Lewellen, T.K.5
Graham, M.M.6
Krohn, K.A.7
32
0028917959
Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia
(1995)
Radiology
, vol.194
, Issue.3
, pp. 795-800
Yang, D.J.1
Wallace, S.2
Cherif, A.3
Li, C.4
Gretzer, M.B.5
Kim, E.E.6
Podoloff, D.A.7
33
0029800972
Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma
(1996)
European Journal of Nuclear Medicine
, vol.23
, Issue.10
, pp. 1378-1383
Yeh, S.H.1
Liu, R.S.2
Wu, L.C.3
Yang, D.J.4
Yen, S.H.5
Chang, C.W.6
Yu, T.W.7
Chou, K.L.8
Chen, K.Y.9